First quarter results from Abbott, Edwards, Intuitive, J&J, Quest and Roche will help reveal the pace of procedure recovery and if the coronavirus testing boom has legs despite the rollout of vaccines.
| CEO Michael Coyle said the wearables company will withdraw its Zio XT cardiac monitor from Medicare fee-for-service segments, adding that he was not optimistic for a reversal.
| Wall Street analysts project the cardiac wearables maker to lose tens of millions of dollars in revenue in coming years, raising questions about the future of the once-hyped market leader.
| The MedTech industry faces rising pressures from health care providers and lower returns from maturing products, in addition to stringent regulations. Discover how adopting digital technologies can help in this
| The medtech is the exclusive global distributor of Cosmo Pharmaceutical's GI Genius module, which has been granted De Novo clearance and is compatible with colonoscope video for identifying polyps and lesions.
| A report prepared for the Agency for Healthcare Research and Quality found available studies "mostly" do not support a link between continuous positive airway pressure therapy and long-term, clinically important outcomes.
| Aiming for a 510(k) submission in 2023 and to grow sales to $1 billion by 2027, the firm with high-profile backers including Bill Gates will face competition from Intuitive, J&J and Medtronic. | Featured Resources FROM: Regulatory Affairs Professionals Society | Get the Latest Regulatory Resources | | Best of What We're Reading  Reuters |
 TechCrunch |
 MobiHealthNews |
 The New York Times |
 STAT |
 MedPage Today | Dive Into a Topic | |
0 Comments